Abstract:Background: The first commercially available photon-counting-detector CT (PCD-CT) has been introduced for clinical use. However, its spectral performance on single- and dual-contrast imaging tasks has not been comprehensively assessed. Purpose: To evaluate the spectral imaging performance of a clinical PCD-CT system for single-contrast material [iodine (I) or gadolinium (Gd)] and dual-contrast materials (I and Gd) in comparison with a dual-source dual-energy CT (DS-DECT). Methods: Iodine (5, 10, and 15 mg/mL) and gadolinium (3.3, 6.6, and 9.9 mg/mL) samples, and their mixtures (I/Gd: 5/3.3 and 10/6.6 mg/mL) were prepared and placed in two torso-shaped water phantoms (lateral dimensions: 30 and 40 cm). These phantoms were scanned on a PCD-CT (NAEOTOM Alpha, Siemens) at 90, 120, and 140 kV. The same phantoms were scanned on a DS-DECT (SOMATOM Force, Siemens) with 70/Sn150, 80/Sn150, 90/Sn150, and 100/Sn150 kV. The radiation dose levels were matched [volume CT dose index (CTDIvol): 10 mGy for the 30 cm phantom and 20 mGy for the 40 cm phantom] across all tube voltage settings and between scanners. Two-material decomposition (I/water or Gd/water) was performed on iodine or gadolinium samples, and three-material decomposition (I/Gd/water) on both individual samples and mixtures. On each decomposed image, mean mass concentration (± standard deviation) was measured in circular region-of-interests placed on the contrast samples. Root-mean-square-error (RMSE) values of iodine and gadolinium concentrations were reported based on the measurements across all contrast samples and repeated on 10 consecutive slices. Results: For all material decomposition tasks on the DS-DECT, the kV pairs with greater spectral separation (70/Sn150 kV and 80/Sn150 kV) yielded lower RMSE values than other DS-DECT and PCD-CT alternatives. Specifically, for the optimal 70/Sn150 kV, RMSE values were 1.2 ± 0.1 mg/mL (I) for I/water material decomposition, 1.0 ± 0.1 mg/mL (Gd) for Gd/water material decomposition, and 4.5 ± 0.2 mg/mL (I) and 3.7 ± 0.2 mg/mL (Gd), respectively, for I/Gd/water material decomposition. On the PCD-CT, the optimal tube voltages were 120 or 140 kV for I/water decomposition with RMSE values of 2.0 ± 0.1 mg/mL (I). For Gd/water decomposition on PCD-CT, the optimal tube voltage was 140 kV with gadolinium RMSE values of 1.5 ± 0.1 mg/mL (Gd), with the 90 kV setting on PCD-CT generating higher RMSE values for gadolinium concentration compared to all DS-DECT and PCD-CT alternatives. For three material decomposition, both imaging modalities demonstrated substantially higher RMSE values for iodine and gadolinium, with 90 kV being the optimal tube potential for Gd/I quantitation on PCD-CT [5.4 ± 0.3 mg/mL (I) and 3.9 ± 0.2 mg/mL (Gd)], and DS-DECT at 100/Sn150 kV having larger RMSE values for both materials compared to the alternatives for either modality. Conclusion: Optimal tube voltage for material decomposition on the clinical PCD-CT is task-dependent but inferior to DS-DECT using 70/Sn150 kV or 80/Sn150 kV in two-material decomposition for single-contrast imaging (iodine/water or gadolinium/water). Three material decomposition (iodine/gadolinium/water) in dual-contrast imaging yields substantially higher RMSE for both imaging platforms.

Direct MR arthrography at 1.5 and 3.0 T: signal dependence on gadolinium and iodine concentrations--phantom study

Direct MR Arthrography of the Shoulder at 3 Tesla: Optimization of Gadolinium Concentration

Intraindividual In Vivo Comparison Of Gadolinium Contrast Agents For Pharmacokinetic Analysis Using Dynamic Contrast Enhanced Magnetic Resonance Imaging

3.0-T Mr Imaging of Intracoronary Local Delivery of Motexafin Gadolinium into Coronary Artery Walls

Intra-individueller In-vivo-Vergleich Von Gd-haltigen MR-Kontrastmitteln Mit Dynamischer Kontrastmittelunterstützter MRT Bei 7T

Efficacy of Whole-Blood Model of Gadolinium-Based Contrast Agent Relaxivity in Predicting Vascular MR Signal Intensity In Vivo

Optimization of Contrast Agent Dosage on Contrast-Enhanced T2 Fluid-Attenuated Inversion Recovery: an in Vitro and in Vivo Study

Quantification of Gd-Dtpa Concentration in Neuroimaging Using T-1 3d Mp-Rage Sequence at 3.0 T

MR Imaging of Articular Cartilage at 1.5T and 3.0T: Comparison of SPGR and SSFP Sequences.

Influence of imaging parameters on the detection of gadolinium concentration in artificial cerebrospinal fluid in fluid-attenuated in version recovery MR Imaging at low field strength

Effect Of Intravenous Gadolinium-Dtpa On Diffusion-Weighted Imaging For Prostate Lesions And Normal Tissue At 3.0-Tesla Magnetic Resonance Imaging

Artificial T1-Weighted Postcontrast Brain MRI

Feasibility of gadofosveset-enhanced steady-state magnetic resonance angiography of the peripheral vessels at 3 Tesla with Dixon fat saturation

The effects of three different contrast agents (Gd-BOPTA, Gd-DTPA, and Gd-DOTA) on brachial plexus magnetic resonance imaging

Low-dose Contrast-Enhanced Magnetic Resonance Imaging of Brain Metastases at 3.0 T Using High-Relaxivity Contrast Agents.

Verification of Quantification of Quantitative Susceptibility Mapping for Estimating the Amount of Gadolinium Deposited in the Brain: a Preliminary Phantom Study

Gadolinium as a CT Contrast Agent: Assessment in a Porcine Model

Contrast-enhanced MR Imaging of Hand and Finger Joints in Patients with Early Rheumatoid Arthritis: Do We Really Need a Full Dose of Gadobenate Dimeglumine for Assessing Synovial Enhancement at 3 T?

Performance evaluation of single- and dual-contrast spectral imaging on a photon-counting-detector CT

Clinically useful dilution factors for iodine and gadolinium contrast material: an animal model of pediatric digital subtraction angiography using state-of-the-art flat-panel detectors

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent